Coherus Oncology, Inc. (CHRS)
1.63
-0.06
(-3.55%)
USD |
NASDAQ |
Mar 13, 16:00
1.635
0.00 (0.00%)
After-Hours: 20:00
Coherus Oncology Shareholders Equity (Quarterly) : 61.01M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Johnson & Johnson | 81.54B |
| Stereotaxis, Inc. | 18.72M |
| Allogene Therapeutics, Inc. | 292.54M |
| Inovio Pharmaceuticals, Inc. | 24.10M |
| Nektar Therapeutics | 89.83M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 265.77M |
| Total Liabilities (Quarterly) | 204.76M |
| Debt to Equity Ratio | 0.891 |
| Current Ratio | 1.472 |
| Net Debt Paydown Yield | 28.50% |